Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03467191Phase 1Active, not recruiting
Phase 1, randomised, double-blind trial (2 arms), sponsored by Carnegie Mellon University. Primary endpoints: Change from Baseline Alcohol Use at 12-months and Change from Baseline Alcohol Use Disorder Symptoms at 12-months. Started Feb 2018; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03467191.